# Zimmer Biomet Holdings Inc. (ZBH)

**Exchange:** NYSE  
**Sector:** Healthcare  
**Market cap:** $17.52B  
**Price:** $88.17 (-1.63%)

> Zimmer Biomet Holdings, Inc. is a medical device company specializing in musculoskeletal healthcare solutions. The company designs, manufactures, and markets orthopedic reconstructive implants for hips, knees, and shoulders, along with a broad range of products for sports medicine, extremities, and trauma surgery. Its portfolio also includes surgical tools, biologics, and digital and robotic technologies that support orthopedic procedures and post-operative care. Zimmer Biomet serves hospitals, ambulatory surgery centers, and healthcare professionals worldwide, focusing on products that enable joint replacement, bone repair, and improved mobility for patients. Following the spin-off of its dental and spine businesses, the company is concentrated on large joint reconstruction and related musculoskeletal products as core areas of activity. Founded in 1927 and headquartered in Warsaw, Indiana, Zimmer Biomet holds a significant position in the global orthopedic market, particularly in the United States, Europe, and Japan, where it is a key supplier to orthopedic surgeons and healthcare systems.

## Income Statement (Annual, USD)

| Fiscal Year | Revenue | Gross Profit | Operating Income | Net Income | EPS (dil.) |
| --- | --- | --- | --- | --- | --- |
| 2025 | $8.23B | — | $1.10B | $705M | — |
| 2024 | $7.68B | — | $1.29B | $904M | — |
| 2023 | $7.39B | — | $1.28B | $1.02B | — |
| 2022 | $6.94B | — | $696M | $231M | — |
| 2021 | $6.83B | — | $860M | $402M | — |
| 2020 | $6.13B | — | $83M | -$139M | — |
| 2019 | $7.98B | — | $1.14B | $1.13B | — |
| 2018 | $7.93B | — | $34M | -$379M | — |
| 2017 | $7.80B | — | $799M | $1.81B | — |
| 2016 | $7.67B | — | $821M | $306M | — |
| 2010 | $4.22B | $3.21B | $917M | $597M | — |
| 2009 | $4.10B | $3.10B | $1.02B | $717M | — |
| 2008 | $4.12B | $3.12B | $1.09B | $849M | — |
| 2007 | $3.90B | $3.02B | $1.13B | $773M | — |

## Balance Sheet (Annual, USD)

| Fiscal Year | Total Assets | Total Liabilities | Equity | Cash | Long-term Debt |
| --- | --- | --- | --- | --- | --- |
| 2025 | $23.09B | $10.39B | $12.70B | $592M | $6.93B |
| 2024 | $21.37B | $8.89B | $12.47B | $526M | $5.34B |
| 2023 | $21.50B | $9.01B | $12.48B | $416M | $4.87B |
| 2022 | $21.07B | $9.04B | $12.02B | $376M | $5.15B |
| 2021 | $23.46B | $10.79B | $12.66B | $378M | $1.00B |
| 2020 | $24.42B | $12.22B | $12.19B | $802M | $7.63B |
| 2019 | $24.64B | $12.25B | $12.39B | $618M | $6.72B |
| 2018 | $24.13B | $12.85B | $11.27B | $543M | $8.41B |
| 2017 | $26.01B | $14.28B | $11.74B | $524M | $8.92B |
| 2016 | $26.68B | $17.01B | $9.67B | $634M | $10.67B |
| 2010 | $8.00B | $2.23B | $5.77B | $669M | $1.14B |
| 2009 | $7.79B | $2.15B | $5.64B | $692M | $1.13B |
| 2008 | $7.24B | $1.59B | $5.65B | $213M | $460M |

## Cash Flow (Annual, USD)

| Fiscal Year | Operating Cash Flow | CapEx | Free Cash Flow |
| --- | --- | --- | --- |
| 2025 | $1.70B | $225M | $1.47B |
| 2024 | $1.50B | $204M | $1.30B |
| 2023 | $1.58B | $291M | $1.29B |
| 2021 | $1.50B | $144M | $1.36B |
| 2020 | $1.20B | $112M | $1.09B |
| 2019 | $1.59B | $207M | $1.38B |
| 2018 | $1.75B | $163M | $1.58B |
| 2017 | $1.58B | $156M | $1.43B |
| 2016 | $1.63B | $185M | $1.45B |
| 2013 | $963M | $100M | $863M |
| 2012 | $1.15B | $115M | $1.04B |
| 2011 | $1.18B | $114M | $1.06B |
| 2010 | $1.19B | $79M | $1.11B |
| 2009 | $1.12B | $105M | $1.01B |
| 2008 | $1.04B | $250M | $788M |

Source: [CompaniesByCap](https://companiesbycap.com/company/ZBH)